Human Reproduction, Vol. 11, No. 7, pp. 1405-1407, 1996
© 1996 European Society of Human Reproduction and Embryology
research-article |
Endocrinology: Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in intracytoplasmic sperm injection cycles
1Centre for Reproductive Medicine, Dutch-speaking Brussels Free University Brussels, Belgium 2ASTA-Medica AG, Frankfurt am Main, Germany
Correspondence: 1To whom correspondence should be addressed
In the present study, subtle serum progesterone rise (
1.1 ng/ml) during the late follicular phase is reported, for the first time to our knowledge, in patients using a potent gonadotrophin-releasing hormone (GnRR) antagonist, Cetrorelix, in combination with human menopausal gonadotrophin (HMG) for ovarian stimulation prior to intracytoplasmic sperm injection (ICSI). In five out of 24 patients (20%) serum progesterone levels were
1.1 ng/ml. The cycle characteristics of the patients were similar in both groups. No premature endogenous luteimzing hor mone (LH) surge occurred and the serum LH concentrations were constantly low during the follicular phase. The l7- oestradiol and follicle stimulating hormone (FSH) exposure were higher in cycles with premature luteinization. The greater oestradiol and FSH exposure confirm that one of the possible factors inducing subtle serum progesterone rise is the increased oestradiol and FSH induced LH receptivity in granulosa cells.
Key words: Cetrorelix/follicular phaselGnRH antagonist/ovarian stimulation/serum progesterone
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. Bosch Comment on: Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. By Venetis et al (2007) Hum. Reprod. Update, March 1, 2008; 14(2): 194 - 195. [Full Text] [PDF] |
||||
![]() |
C.A. Venetis, E.M. Kolibianakis, E. Papanikolaou, J. Bontis, P. Devroey, and B.C. Tarlatzis Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis Hum. Reprod. Update, July 1, 2007; 13(4): 343 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Nawroth and M. Ludwig What is the 'ideal' duration of progesterone supplementation before the transfer of cryopreserved-thawed embryos in estrogen/progesterone replacement protocols? Hum. Reprod., May 1, 2005; 20(5): 1127 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Hwang, L.-W. Huang, B.-C. Hsieh, Y.-L. Tsai, S.-C. Huang, C.-Y. Chen, M.-L. Hsieh, P.-H. Chen, and Y.-H. Lin Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles Hum. Reprod., January 1, 2003; 18(1): 45 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Filicori, G.E. Cognigni, P. Pocognoli, C. Tabarelli, D. Spettoli, S. Taraborrelli, and W. Ciampaglia Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration Hum. Reprod., August 1, 2002; 17(8): 2009 - 2015. [Abstract] [Full Text] [PDF] |
||||

